The research focuses on understanding the molecular basis of chemoresistance and immune-resistance in human tumors, the onset and therapeutic responses of inflammatory bowel diseases through genomics and metagenomics, and the development and validation of innovative nanomedicine therapies, including metallic, bi-metallic, liposomes, polymers, and hybrid systems.
Maria Gazouli, a biologist, is a Professor of Biology – Nanomedicine at the Department of Biology at the National & Kapodistrian University of Athens (NKUA), School of Medicine. She completed her first PhD training at the Department of Biology, School of Science of NKUA, in partnership with the Hellenic Pasteur Institute, and her second PhD training at the Department of Microbiology, School of Medicine of NKUA. She conducted her postdoctoral work in the USA at the Cell Biology and Pharmacology Department, Georgetown University Medical Center, Washington DC. From 2000 to 2001, Dr. Gazouli was a Research Fellow at NCSR Demokritos, Institute of Biology, and from 2001 to 2003, she was a Research Fellow at the Department of Histology – Embryology, School of Medicine, NKUA. From 2004 to 2006, she served as a technical scientific staff member at the Laboratory of Biology, School of Medicine, NKUA. In 2007, she joined the NKUA Medical School as a Lecturer of Biology. In 2012, she was promoted to Assistant Professor of Molecular Biology, in 2016 to Associate Professor of Molecular Biology, and in 2020 to Professor of Biology – Genetics - Nanomedicine.
Dr. Gazouli's work primarily focuses on the molecular basis of diseases, particularly autoimmune diseases and cancer, as well as the molecular detection of pathogens and the investigation of the pathogenesis of the diseases they cause in humans. Recently, she has incorporated nanotechnology to target cancer detection, imaging, and drug delivery. She was honored with a Fulbright Scholarship for the development of nanotechnology-based biosensor arrays for the detection of circulating colorectal cancer cells at the University of Maryland, College Park, MD, USA.
Dr. Gazouli's work is reflected in over 350 publications that have received more than 15,800 citations, with an h-index of 64 (Google Scholar, 1/1/2024). She holds one granted international patent and three European patents. She has delivered more than 60 invited lectures at international and national conferences and universities and has trained several junior scientists. Dr. Gazouli has served as an ad hoc reviewer for various scientific journals and as an expert evaluator for national and international research grant funding agencies. She has been the scientific coordinator of European Commission-funded collaborative research programs. Dr. Gazouli teaches Biology, Genetics, and Nanomedicine to undergraduate medical students and in master's programs. Currently, she is a National Representative at the Committee of Advanced Therapies (CAT) of the European Medicine Association.
Duration | Fee |
---|---|
2 weeks | $875.00 |
6 weeks | $1,500.00 |
12 weeks | $2,750.00 |
This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.
All
Host Name: Maria Gazouli
Affiliation: National and Kapodistrian University of Athens Greece
Address: National and Kapodistrian University of Athens Greece
Website URL: https://en.uoa.gr/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Dec 1st, 2024
Duration | Fee |
---|---|
2 weeks | $875.00 |
6 weeks | $1,500.00 |
12 weeks | $2,750.00 |
This program allows Merit Applications. This program allows merit-based applications for virtual and onsite clinical and research programs. If you are successfully awarded under this category, Trialect or the host mentor will cover the tuition fee only. All applications will be evaluated based on merit. Due to the high level of competition, the chances of being selected under the merit category are quite limited.
All
Host Name: Maria Gazouli
Affiliation: National and Kapodistrian University of Athens Greece
Address: National and Kapodistrian University of Athens Greece
Website URL: https://en.uoa.gr/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.